Jeffrey N. Weitzel

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

M. William Audeh, James Carmichael, Richard T. Penson et al. · The Lancet · 2010 · 2.3K citations

Medicine, Cancer Management, Gynecology +7

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Andrew Tutt, Mark E. Robson, Judy E. Garber et al. · The Lancet · 2010 · 1.6K citations

Breast Oncology, Oncology, Pathology +6

A Population-Based Study of Genes Previously Implicated in Breast Cancer

Chunling Hu, Steven N. Hart, Rohan Gnanaolivu et al. · New England Journal of Medicine · 2021 · 804 citations · Full text

Genetic/Familial High-Risk Assessment: Breast and Ovarian

Mary B. Daly, Jennifer E. Axilbund, Saundra S. Buys et al. · Journal of the National Comprehensive Cancer Network · 2010 · 649 citations · Full text

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017

Mary B. Daly, Robert Pilarski, Michael P. Berry et al. · Journal of the National Comprehensive Cancer Network · 2016 · 647 citations · Full text

Family Medicine, Genetic Testing, Breast Oncology +24